Chronic Urticaria, Idiopathic Clinical Trial
Official title:
Molecular Endotypes of Chronic Idiopathic Urticaria
This study plans to learn more about why some people with Chronic Idiopathic Urticaria (CIU) respond to treatment with omalizumab (Xolair). It will test people before they receive treatment with omalizumab as part of standard of care, to see if there are differences in their blood and skin that can predict who responds to treatment.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05916937 -
Extending Omalizumab Treatment Intervals in Patients With Chronic Spontaneous Urticaria
|
Phase 4 |